Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UPDATE: Devon Energy Releases Q2 Results (Link To Presentation)

https://s2.q4cdn.com/462548525/files/doc_financials/quarterly/2022/q2/Q2-2022-DVN-Earnings-Presentation.pdf

byBenzinga Newsdesk

August 1, 2022

1 minute read

https://s2.q4cdn.com/462548525/files/doc_financials/quarterly/2022/q2/Q2-2022-DVN-Earnings-Presentation.pdf

Wells Fargo Maintains Equal-Weight on Seagate Tech Hldgs, Lowers Price Target to $90

By Benzinga Newsdesk

Today, 2:27 PM

Wells Fargo analyst Aaron Rakers maintains Seagate Tech Hldgs (NASDAQ:STX) with a Equal-Weight and lowers the price target from $110 to $90.

STX

Genworth Financial Q4 EPS $0.33 Beats $0.20 Estimate

By Bill Haddad

Today, 2:27 PM

Genworth Financial (NYSE:GNW) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.20 by 65 percent. This is a 3.13 percent increase over earnings of $0.32 per share from the

GNW

RBC Capital Maintains Outperform on American Homes 4 Rent, Raises Price Target to $45

By Benzinga Newsdesk

Today, 2:27 PM

RBC Capital analyst Brad Heffern maintains American Homes 4 Rent (NYSE:AMH) with a Outperform and raises the price target from $43 to $45.

AMH

BeiGene Presents Clinical Data From 2 Phase 2 Trials Of Pamiparib At 2021 ASCO Meeting

By Benzinga Newsdesk

Today, 2:27 PM

Pamiparib, a potent and selective PARP1 and PARP2 inhibitor, demonstrated meaningful and durable efficacy in patients with advanced HER2-negative breast cancer Pamiparib showed numerically higher progression-free

BGNE

UPDATE: Devon Energy Releases Q2 Results (Link To Presentation)

Related Posts

Wells Fargo Maintains Equal-Weight on Seagate Tech Hldgs, Lowers Price Target to $90

Genworth Financial Q4 EPS $0.33 Beats $0.20 Estimate

RBC Capital Maintains Outperform on American Homes 4 Rent, Raises Price Target to $45

BeiGene Presents Clinical Data From 2 Phase 2 Trials Of Pamiparib At 2021 ASCO Meeting